1800 202 8726
After your biopsy result

Follow-Up After — a Negative Biopsy

A negative biopsy means no cancer was found in the tissue that was sampled. It is an important result, and it is also the beginning of a plan — not the end of one.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026

  • Follow-up is standard — A negative result does not automatically close the case, especially when clinical suspicion before the biopsy was significant.
  • Biopsies sample, not survey — A needle takes a small portion of tissue. What it does not reach cannot be reported.
  • Your team uses more than one piece of information — Imaging, symptoms, and examination findings all stay part of the picture alongside the biopsy result.
  • The plan protects you — Surveillance after a negative biopsy is not distrust of the result — it is the standard of care.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Yes, follow-up is needed after a negative biopsy. A biopsy samples a small part of the tissue, and what the needle does not reach cannot be reported. Your team will set a surveillance plan — repeat imaging, clinical review, or a repeat biopsy — based on what prompted the test. Ask your oncologist what that plan looks like for your situation.

What happens after a negative biopsy result?

  1. Review appointment

    Your oncologist goes through the pathology report with you and explains what the laboratory found in the sampled tissue.

  2. Risk assessment

    Your team weighs the negative result against everything that prompted the biopsy: the imaging, the clinical examination, and any symptoms you reported.

  3. Surveillance plan

    Based on that assessment, your team sets a schedule — when you return, what tests come next, and what signs to report in between appointments.

  4. Monitoring

    You attend follow-up visits and, if scans are part of the plan, repeat imaging at set intervals to confirm the original concern is stable or resolved.

  5. Discharge or extended follow-up

    When your team is satisfied the concern is genuinely resolved, they tell you what to do if something changes in future. Some patients remain on longer surveillance depending on the original finding.

Does a negative result mean I definitely do not have cancer?

A negative biopsy means cancer was not found in the tissue the needle reached. It does not mean cancer cannot exist in tissue the needle did not sample.

This is a known technical limitation, not a failure of the procedure. ESMO and NCCN guidance formally recognises it as sampling variation — no biopsy can examine every cell in the area of interest.

Your oncologist does not rely on the biopsy result alone. The imaging, the clinical examination, and the symptoms that led to the test all remain part of the assessment. That is why surveillance continues when the original concern was significant.

What is your team watching for during follow-up?

Your team is confirming that the concern which prompted the biopsy resolves or stays stable over time.

They will watch for new or worsening symptoms, changes on imaging if repeat scans are part of your plan, and any clinical findings that suggest the picture has shifted.

Continuing to follow you is not a sign that your team distrusts the result. NCCN and ESMO guidance recommends surveillance after a negative biopsy when the original clinical suspicion was significant — it is the standard approach.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Words your team may use

Negative biopsy
The tissue sample sent to the laboratory showed no cancer cells. It describes what was found in that specific sample, not the entire organ or region.
Sampling variation
A technical limitation of any biopsy. The needle takes a small portion of tissue, and an area of concern may not fall within that portion.
Surveillance
A scheduled programme of follow-up appointments and tests to monitor a concern over time. Being on surveillance does not mean your team expects to find cancer.
Clinical suspicion
The combination of symptoms, imaging findings, and examination findings that led your team to recommend the biopsy. Higher clinical suspicion usually means a more intensive follow-up schedule.
False negative
A result that reports no cancer when cancer is present — usually because the needle did not reach the affected tissue. Your team's surveillance plan is designed to account for this possibility.

How long does follow-up continue after a negative biopsy?

The duration depends on the organ, the degree of clinical suspicion before the biopsy, and how repeat imaging looks over time.

A biopsy prompted by a low-risk finding usually needs less intensive follow-up than one prompted by a highly suspicious lesion. NCCN and ESMO recommendations vary by site, so the schedule your team sets is specific to your situation.

At your next appointment, ask your oncologist how many visits are planned, what findings would change that schedule, and what symptoms should prompt you to call before your next appointment.

Questions people ask after a negative biopsy

Should I get a second opinion on the biopsy pathology?

A second opinion on the pathology report is a reasonable request and one your oncologist can help arrange. It is most useful when the result is unexpected given what the imaging showed, when the tissue sample was very small, or when you remain significantly worried after your review appointment. Your oncologist can send the same glass slides to another laboratory without a new biopsy being needed. Asking for a second opinion is a normal part of cancer care and should not delay your surveillance plan.

My symptoms have not gone away. What should I do?

Tell your team at your next appointment — or call before it if the symptoms are new, worsening, or clearly different from before the biopsy. Persistent symptoms after a negative result are something your oncologist needs to know about. They may prompt earlier repeat imaging or a repeat biopsy. Do not assume that the negative result explains ongoing symptoms, and do not wait for your scheduled visit if things are getting worse.

Can I ask for a repeat biopsy if I am not reassured?

Yes, and in some situations your team will recommend one without you asking. A repeat biopsy is most likely to be suggested when the imaging and the biopsy result do not fit together, when the original tissue sample was small or taken from a difficult position, or when your symptoms have continued or changed. If you feel your concern is not being addressed, say so clearly at your appointment. A second clinical opinion from another oncologist is also an option open to you.

What does it mean if my imaging still looks suspicious?

A mismatch between a negative biopsy and a suspicious-looking scan is something your team takes seriously. It does not mean one is right and the other is wrong — it means both pieces of information together need to be interpreted, which is a clinical judgement that cannot be made from a report alone. Your oncologist may recommend closer follow-up imaging, a biopsy from a different part of the area, or a referral for a second opinion. Tell your team if this is your situation and ask them to explain the plan clearly.

Will traditional or herbal medicines affect my follow-up?

Some herbal and traditional preparations can affect imaging results or blood markers, and a few interact with medicines that might be prescribed if a further procedure becomes necessary. We do not ask you to stop any practice that matters to you. We do ask you to tell your treating team exactly what you are taking — including the name and dose — so they can factor it in. This includes Ayurvedic, Unani, homeopathic, and any other preparations, however familiar or gentle they seem.

Do follow-up scans involve radiation?

Some surveillance plans include CT or PET-CT imaging, which uses ionising radiation. PET-CT at CION is coordinated through partner imaging centres, and your oncologist chooses the scan type based on what gives the clearest picture of your specific concern. The dose from a single diagnostic scan is at a level that IAEA and ICMR consider acceptable for diagnostic purposes. Ultrasound and MRI do not use ionising radiation and are used for surveillance in many situations. If radiation is a concern, raise it with your oncologist and ask which scan type applies to your follow-up plan.

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

HUB — How Accurate Is a Biopsy? Repeats, Errors and Second Opinions

HUB — IHC and Molecular Markers on a Biopsy

HUB — Labs, Slides and Second Opinions on a Biopsy

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Does a negative biopsy mean I am safe?

A negative biopsy means no cancer was found in the tissue the needle sampled. Whether that fully resolves the concern depends on what prompted the biopsy in the first place. When the original concern was significant — based on imaging or clinical findings — your team will continue to monitor you rather than treating the case as closed on a single result. Your oncologist is the right person to tell you what your specific result means in the context of your full clinical picture.

How often are biopsies wrong?

Biopsy accuracy varies by organ site, the technique used, the size of the lesion, and how many samples were taken. ESMO and NCCN guidance acknowledges sampling variation as a real limitation without giving a single universal figure, because no single figure applies across all situations and cancer types. Your oncologist can tell you how confident they are in the result for your specific case, based on factors such as the quality of the sample and how clearly the biopsy site was seen on imaging.

What should I do if new symptoms appear between follow-up appointments?

Call your oncology team rather than waiting for your next scheduled visit. New symptoms — particularly pain, a new lump, unexplained weight loss, or anything that feels clearly different from before — are exactly the kind of change your team needs to know about promptly. Do not interpret a negative biopsy as a reason to wait and see. The surveillance plan exists for this situation, and contacting your team early does not inconvenience them.

Will I need a repeat biopsy?

Not necessarily, but it is possible. A repeat biopsy is recommended when imaging continues to show a suspicious area, when the first sample was small or taken from a technically difficult position, or when your symptoms change after the initial result. If your surveillance imaging shows the area is stable and your symptoms have settled, a repeat biopsy may not be needed at all. Your oncologist will tell you clearly what findings would lead them to recommend one.

What is the difference between a true negative and a false negative?

A true negative is a result that correctly reports no cancer because no cancer is present. A false negative is a result that reports no cancer when cancer is actually there — usually because the needle did not reach the affected tissue. Neither you nor your team can determine from the report alone which type it is. That is precisely why surveillance continues. If the area of concern stays stable on imaging and your symptoms resolve over time, a true negative becomes more likely.

Can I ask my oncologist to explain the result again?

Yes, and you should if anything was unclear at your first appointment. Bring a family member or write your questions down beforehand. It is reasonable to ask: what exactly was found in the sample, why follow-up is or is not being recommended, and what changes would prompt the team to revise the plan. Your team expects these questions. A clear explanation of your result and what comes next is part of the care you are entitled to receive.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation